The nation of Zimbabwe has declined a significant American healthcare agreement valued at 367 million US dollars (£272m) spanning five years due to Washington's request for confidential information.
This move became public following a government memo dated December was disclosed, which showed Head of State Emmerson Mnangagwa believed the arrangement was "skewed".
A government spokesman later explained that the US was demanding access to genetic material for research and profit while refused to share the resulting advantages from future medical innovations.
"We will now turn to the difficult and regrettable task of ending our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy said the US had furnished over $1.9bn in health funding to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has called for continued talks to secure a deal agreeable to both sides so the country's vital HIV programme can continue.
Broader Background
This development comes after a similar situation in neighbouring Kenya, where a court halted a related health funding agreement following legal challenges were raised about the security of citizens' medical information.
Since returning to the presidency recently, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).
The agency had managed aid for the US government, but Trump stated its spending was "wasteful" and his administration was pursuing government-to-government agreements to boost transparency and responsibility.
Based on statements, 16 African countries have so far agreed to similar agreements, representing more than $18.3bn in committed funds.
Details of the Rejected Deal
The money for Zimbabwe would have funded "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this partnership might have yielded immense benefits for the people of Zimbabwe, particularly the 1.2 million currently on antiretroviral therapy via American-funded initiatives," Tremont added.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unfair".
"The proposal required Zimbabwe to surrender its genetic material and health information for a long time, without any equivalent promise of benefiting from any scientific breakthroughs – such as new medicines or tests – that might be developed from that provided information," his statement read.
"Effectively, our nation would provide the basic resources for scientific discovery with no assurance that the final treatments would be available to our population should a new disease outbreak emerge."
National Interest and Global Health
He also pointed out that the American exit from the global health body and its push of one-on-one health agreements were upending systems already established through the international organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing framework designed to deal with potential pandemics.
"This framework is intended to guarantee that when a nation contributes its information, the benefits – including medicines and cures – are distributed fairly, not monopolised solely by those with the funds to create them."
These objections regarding the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We encourage ongoing dialogue with our US partners on how future co-operation might be arranged in a way that honours the independence and interests of each country."
Health Experts Response
Medical experts said it acknowledged the official position, but recommended that negotiations must proceed considering much of the country's HIV programmes were funded by foreign aid.
"Where technical issues exist, such as those relating to information security or agreement terms, these can often be addressed through technical clarification and negotiated safeguards," the group added.
This impasse emphasises the complex tensions between accepting crucial foreign assistance and safeguarding local interests in an increasingly interconnected world.